Skip to main content
SpringerLink
Log in

Anticoagulant-related hospitalisations: costs examined

  • Epidemiology population study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Programme de Médicalisation des Systèmes d'Information

  2. Anticoagulant-related hospital admissions (public & private) were extracted from the PMSI database using two International Classification of Diseases, 10th revision (ICD-10) codes: "T45.5 - Poisoning by anticoagulants' and 'Y44.2 - Anticoagulants' adverse effect in therapeutic use'.

References

  1. Heng C, et al. Anticoagulant-related hospital admissions: serious adverse reactions identified through hospital databases. Pharmacoepidemiology and Drug Safety : 31 Jul 2014. Available from: URL: http://doi.org/10.1002/pds.3688

    PubMed  Google Scholar 

  2. Medicines and Healthcare products Regulatory Agency (UK). Regulator launches learning module on oral anticoagulants. Internet Document : 5 Aug 2014. Available from: URL: http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON444302

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anticoagulant-related hospitalisations: costs examined. Reactions Weekly 1515, 8 (2014). https://doi.org/10.1007/s40278-014-2703-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-2703-7

Search

Navigation